PCC0105005
PCC0105005 is a dual-target CGRP Receptor antagonist (IC50 = 1.01 nM) and a partial agonist of 5-HT1F Receptor (EC50 = 77.91 nM). PCC0105005 shows significant efficacy in the rat model of migraine. PCC0105005 significantly reduces the expression of CGRP and c-Fos proteins, and inhibits the phosphorylation levels of ERK and CREB. PCC0105005 can be used for research on migraine.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2921670-99-5
- Formule: C51H63N11O4
- Masse moléculaire:894.12
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform 5-HT Receptor
More
Activité biologique
|
5-HT1F Receptor 77.91 nM (IC50) |
ERK |
Chemical Information
-
CAS No. 2921670-99-5
-
Masse moléculaire 894.12
-
Formule C51H63N11O4
-
SMILES
CN(CC1)CCC1C2=CNC3=CC=C(NC(C4=CC(C=C(C5CCN(C(N[C@H](CC6=CC(C)=C(NN=C7)C7=C6)C(N8CCN(C9CCN(C)CC9)CC8)=O)=O)CC5)C(N%10)=O)=C%10C=C4)=O)C=C32
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- PCC0105005
- 2921670-99-5
- PCC 0105005
- PCC-0105005
- CGRP Receptor
- 5-HT Receptor
- ERK
- Epigenetic Reader Domain
- Dual-target therapeutics
- CGRP antagonists
- 5-HT1F agonists
- migraine treatment
- structure-based drug design
- pharmacokinetics
- peripheral restriction
- trigeminovascular system
- neurogenic inflammation
- pain threshold
- Inhibitor
- inhibitor
- inhibit